"In looking for a highly speculative stock for our portfolio, I have settled on MannKind Corp. (NASDAQ: MNKD), a company that is developing an inhaled insulin product," says Nate Pile.

In his growth-oriented Nate's Notes, the advisor cautions, "I believe we are looking at

"How does one go about investing in the antibody space?" asks biotech specialist John McCamant. In The Medical Technology Stock Letter, he eyes Immunogen (NASDAQ: IMGN).

"The company will continue to benefit from Genetech's extensive antibody experience as they continue to run all development for Immunogen's

"In the 2000s, as we’ve alternated between deflationary and inflationary worries, gold has been the only major investment to rise every year," says Stephen Leeb.

In his The Complete Investor, he explains, "We think that many miners are exceptional bets today. And among our favorite gold

As many of you have noticed, the stock index Futures have had a drastic cut in volatility since their all-time high volatility in October. At that time, the ES (E-mini S&P) had an ATR (Average True Range) of approximately 90 handles (full points). That is about $4,500 per